Top Oncology Deal-Makers Gather at Windhover's Oncology Partnering Event to Address Translating Oncology Research into (Business Wire via Yahoo! Finance)
NORWALK, Conn.----May 1, 2006--Top pharmaceutical and biotechnology oncology executives discuss the targets, products and companies to watch at Windhover's Oncology Partnering event.

Par Pharmaceutical Reports First-Quarter Sales and Earnings (FinanzNachrichten)
SPRING VALLEY, N.Y., May 1 /PRNewswire-FirstCall/ -- Par Pharmaceutical ( Nachrichten ) Companies, Inc. today reported that total revenues grew 78 percent to $173.8 million for the first quarter ended April 2, 2006. For the quarter, income from continuing operations rose 212 percent to $8.4 million and diluted earnings per share from continuing operations increased 200 percent to $.24. This is